:: Would cervical cancer vaccine promote unsafe sex? ::
A revolutionary vaccine that could end cervical cancer and save thousands of lives could be available by next year.
The drug Gardasil has proven 100-percent effective against two strains of the human papilloma virus (HPV) that trigger 70 percent of cervical cancers. No significant side effects were reported during the trial. The drug also acts against virus strains that cause genital warts.
Merck has applied to the U.S. Food and Drug Administration for a licence to market the vaccine in America. The French pharmaceuticals company Sanofi Pasteur MSD is applying for a license to market Gardasil in 25 European countries. The process usually takes 12 months to complete.
The vaccine comes with controversy, though. Since HPV is transmitted through sexual contact, some have suggested that girls as young as 10 years old be vaccinated to make sure they're protected before becoming sexually active. Some critics say treating young girls with the vaccine may encourage underage sex.
Cervical cancer affects 470,000 women a year worldwide. It can be deadly, if not detected and treated early. Yearly Pap smears can help doctors spot early warning signs.
